Jobs / United States / Novartis Pharmaceuticals Corporation
Therapy Area Representative
Novartis Pharmaceuticals Corporation · 🇺🇸 Kuwait
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Novartis Pharmaceuticals Corporation
The US Department of Labor certified 75 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Novartis Pharmaceuticals Corporation →
About the role
Job Description Summary We are hiring for a Therapy Area Representative to join our Commercial Portfolio Team based in Kuwait. The TA Representative in Kuwait will be responsible for supporting HQ by executing the in-field tactics for assigned priority brands within a defined territory. The role focuses on high-quality external stakeholder engagement and delivery of agreed field performance objectives, in line with Novartis policies, ethical standards, and compliance requirements. #LI-Onsite Job Description Major accountabilities: • Execute data-driven field engagement and delivering tailored omnichannel interactions using digital tools • Deliver high-quality, compliant product promotion aligned with brand strategy and therapeutic area priorities • Act as a trusted partner to HCPs by communicating clinical evidence, product value, and appropriate use • Leverage “next best action” insights and digital platforms to maximize engagement impact and execution excellence • Capture and share field insights on customer needs, market dynamics, and competitor activity to inform strategy and territory planning • Collaborate cross-functionally and operate in full compliance with company policies, ethical standards, and local regulations Requirements: • Degree/education in relevant discipline. • Solid understanding of Kuwait market is preferred. • Ability to execute omnichannel stakeholders journeys effectively • Can demonstrate successful performance track record • Solid communication skills, analytical skills, and presentation skills. • Strong external stakeholders engagement and relationship management skills. • Proven ability to use digital/AI tools as part of daily work. Skills Desired Commercial Excellence, Conflict Management, Cross-Functional Coordination, Customer Insights, Influencing Skills, Key Account Management, Professional Ethics